Literature DB >> 3159726

Heparan sulfate proteoglycans from mouse mammary epithelial cells. Cell surface proteoglycan as a receptor for interstitial collagens.

J E Koda, A Rapraeger, M Bernfield.   

Abstract

A heparan sulfate-rich proteoglycan is on the surface of NMuMG mouse mammary epithelial cells apparently intercalated into their plasma membranes. Mild treatment of the cells with trypsin releases the GAG-bearing region (ectodomain) of this molecule as a discrete proteoglycan which is readily purified. At physiological pH and ionic strength, the ectodomain binds collagen types I, III, and V but not types II, IV, or denatured type I. The proteoglycan binds to a single class of high affinity saturable sites on type I collagen fibrils, sites which are selective for heparin-like glycosaminoglycans. The binding of NMuMG cells to type I collagen duplicates that of their cell surface proteoglycan; cells bind to native but not denatured collagen, and binding is inhibited by heparin but not by other glycosaminoglycans. These binding properties suggest that cell surface heparan sulfate proteoglycans could act as receptors for interstitial collagens and mediate changes in cell behavior induced by collagenous matrices.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3159726

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  72 in total

1.  Molecular cloning of amphiglycan, a novel integral membrane heparan sulfate proteoglycan expressed by epithelial and fibroblastic cells.

Authors:  G David; B van der Schueren; P Marynen; J J Cassiman; H van den Berghe
Journal:  J Cell Biol       Date:  1992-08       Impact factor: 10.539

2.  The extracellular matrix modulates olfactory neurite outgrowth on ensheathing cells.

Authors:  K T Tisay; B Key
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

3.  Non-enzymatic glycation of type I collagen diminishes collagen-proteoglycan binding and weakens cell adhesion.

Authors:  Kristin L Reigle; Gloria Di Lullo; Kevin R Turner; Jerold A Last; Inna Chervoneva; David E Birk; James L Funderburgh; Elizabeth Elrod; Markus W Germann; Charles Surber; Ralph D Sanderson; James D San Antonio
Journal:  J Cell Biochem       Date:  2008-08-01       Impact factor: 4.429

Review 4.  Biological functions of proteoglycans: use of specific inhibitors of proteoglycan synthesis.

Authors:  D J Carey
Journal:  Mol Cell Biochem       Date:  1991 May 29-Jun 12       Impact factor: 3.396

Review 5.  The mutual impact of syndecan-1 and its glycosaminoglycan chains--a multivariable puzzle.

Authors:  Anna S Eriksson; Dorothe Spillmann
Journal:  J Histochem Cytochem       Date:  2012-08-16       Impact factor: 2.479

6.  Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells.

Authors:  M Kato; S Saunders; H Nguyen; M Bernfield
Journal:  Mol Biol Cell       Date:  1995-05       Impact factor: 4.138

7.  Defining the domains of type I collagen involved in heparin- binding and endothelial tube formation.

Authors:  S M Sweeney; C A Guy; G B Fields; J D San Antonio
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

8.  Identification of cell adhesive active sites in the N-terminal domain of thrombospondin-1.

Authors:  P Clezardin; J Lawler; J Amiral; G Quentin; P Delmas
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

9.  In vivo and in vitro regulation of syndecan 1 in prostate cells by n-3 polyunsaturated fatty acids.

Authors:  Iris J Edwards; Haiguo Sun; Yunping Hu; Isabelle M Berquin; Joseph T O'Flaherty; J Mark Cline; Lawrence L Rudel; Yong Q Chen
Journal:  J Biol Chem       Date:  2008-04-30       Impact factor: 5.157

10.  Interaction of human papillomavirus type 16 particles with heparan sulfate and syndecan-1 molecules in the keratinocyte extracellular matrix plays an active role in infection.

Authors:  Zurab Surviladze; Rosa T Sterkand; Michelle A Ozbun
Journal:  J Gen Virol       Date:  2015-08       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.